Does Zepbound Cause Hair Loss? Biomarker & Clinical Review

Last reviewed: May 27, 2026

Last updated: May 27, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Hair loss associated with GLP-1 receptor agonists like Zepbound is typically related to rapid weight loss and nutrient depletion rather than the medication itself. Clinical data suggests telogen effluvium—temporary shedding triggered by metabolic stress—accounts for most reported cases, with incidence varying widely among users.

PlexusDx approaches this concern through precision wellness: understanding your metabolic biomarkers and genetic predispositions before starting treatment may help identify who faces higher risk. This personalized context supports a more informed conversation with your provider about monitoring strategies and nutritional support during weight management therapy.

How Rapid Weight Loss Triggers Hair Shedding

When the body loses weight quickly, hair follicles shift from active growth phase to telogen phase, where they rest before shedding. This process isn't unique to GLP-1 drugs—it occurs with any significant caloric deficit. Studies show patients losing more than 1–2 pounds weekly face elevated telogen effluvium risk.

The timing matters: hair loss typically appears 2–3 months after rapid weight loss begins, as dormant follicles complete their cycle. Most cases resolve within 6–12 months once weight stabilizes and nutritional status improves, though individual recovery varies based on baseline nutrient levels and metabolic health.

Nutritional and Metabolic Factors That Increase Hair Loss Risk

GLP-1 therapy reduces appetite and food intake, which can deplete key nutrients needed for hair growth: iron, zinc, biotin, and protein. Patients with pre-existing deficiencies face compounded risk. Biomarker screening before treatment helps identify who requires targeted nutritional intervention during weight loss.

Below are critical nutrient markers and their role in hair health during GLP-1 therapy.

Nutrient	Hair Loss Connection	Typical Screening Method
Iron (Ferritin)	Deficiency impairs follicle protein synthesis; low ferritin correlates with telogen effluvium severity	Serum ferritin; TIBC
Zinc	Essential cofactor for keratin production; deficiency halts follicle growth phase	Serum zinc; consider plasma zinc for accuracy
Protein/Albumin	Hair shaft is primarily keratin protein; inadequate intake directly slows regrowth	Serum albumin; 24-hour urinary nitrogen
Vitamin D & B12	Support hair follicle cycling and metabolic function; deficiencies linked to alopecia patterns	25-OH vitamin D; serum B12 and methylmalonic acid

Genetic Predisposition in Hair Loss Susceptibility

Individual variation in hair loss risk during weight loss relates partly to genetic factors influencing metabolism and nutrient absorption. Variants in genes affecting protein synthesis, micronutrient metabolism, and follicle sensitivity may modulate who experiences severe versus mild shedding during rapid weight change.

PlexusDx Precision Peptide Genetic Test examines predispositions in peptide signaling pathways—including metabolic efficiency and nutrient response—that may provide context for how your body responds to rapid metabolic shifts. This information should be interpreted with a qualified provider to guide preventive nutritional strategies.

Risk Mitigation Strategies and Provider Guidance

Preventing or minimizing hair loss during GLP-1 therapy requires a multi-pronged approach: slower titration (to reduce weekly weight loss velocity), adequate protein intake (1.2–1.6g/kg body weight), micronutrient repletion, and biomarker monitoring every 6–8 weeks. Your provider should assess baseline nutrient status before starting treatment.

If hair loss occurs, it should trigger biomarker reassessment and possible temporary dose adjustment or supplementation pause to allow dietary absorption. Hair loss alone is not a reason to stop therapy, but it is a clinical signal warranting intervention. PlexusDx can help contextualize your metabolic profile to support these decisions.

How PlexusDx Supports a More Personalized Approach

PlexusDx genetic predisposition testing may help provide context for individual metabolic variation during weight loss. Variants in pathways affecting protein metabolism, iron absorption, and nutrient signaling can inform your provider about personalized nutritional needs during GLP-1 therapy, potentially reducing hair loss severity.

The Precision Peptide Genetic Test reveals predispositions in key metabolic genes—such as FTO (energy metabolism) and other nutrient-related variants—that should be interpreted with a qualified healthcare provider. This test does not predict exact medication response or guarantee prevention of side effects, but may support a more tailored nutritional monitoring plan.

Understanding your genetic and biomarker context before starting weight management treatment can help your provider design a preventive strategy: appropriate supplementation, monitoring schedules, and dose titration. This conversation becomes especially valuable if you have personal or family history of hair loss or nutrient absorption issues.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Does Zepbound itself cause hair loss, or is it the weight loss?

Hair loss is primarily triggered by rapid weight loss and nutrient depletion, not Zepbound's active ingredient directly. The medication causes appetite reduction, which leads to caloric deficit. Any significant weight loss can cause temporary telogen effluvium.

How long does hair loss from GLP-1 therapy typically last?

Most patients experience peak shedding 2–4 months into treatment, with recovery over 6–12 months once weight stabilizes and nutrient status improves. Duration varies based on baseline nutrition, weight loss rate, and individual metabolic recovery.

Can I use a compounded GLP-1 medication and avoid hair loss?

Hair loss risk exists with any rapid weight loss, regardless of branded or compounded GLP-1 source. PlexusDx compounded semaglutide and tirzepatide offer cost-effective options. Slower titration and proactive nutrient monitoring reduce risk with any formulation.

What supplements or nutrients should I take during GLP-1 therapy?

Before supplementing, consult your provider and get baseline biomarkers (iron, zinc, vitamin B12, vitamin D, albumin). Supplementation should target deficiencies, not be blanket. Excess supplementation can interfere with medication absorption or cause toxicity.

How does the Precision Peptide Genetic Test help with hair loss prevention?

The test reveals predispositions in metabolic and nutrient-handling pathways that may inform personalized nutritional support strategies. Results should be discussed with your provider to design preventive monitoring and supplementation if warranted before or during GLP-1 therapy.

Does Zepbound Cause Hair Loss: Biomarker Context and Clinical Evidence